Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy

BACKGROUND: Beta-adrenergic antagonists or blockers (BB) are a cornerstone of cardiac therapy for multiple indications. However, BB are considered relatively contraindicated in amyloid cardiomyopathy due to poor tolerance. This intolerance is hypothesized to be due to concomitant neuropathy and sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramsell, Stuart, Arias Bermudez, Carlos, Takem Baiyee, Cyril Ayuk Mbeng, Rodgers, Brandon, Parikh, Samir, Almaani, Salem, Sharma, Nidhi, LoRusso, Samantha, Freimer, Miriam, Redder, Elyse, Bumma, Naresh, Vallkati, Ajay, Efebera, Yvonne, Kahwash, Rami, Campbell, Courtney M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309481/
https://www.ncbi.nlm.nih.gov/pubmed/35898273
http://dx.doi.org/10.3389/fcvm.2022.907597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309481/
https://www.ncbi.nlm.nih.gov/pubmed/35898273
http://dx.doi.org/10.3389/fcvm.2022.907597

Ejemplares similares